×

Adverse reaction monitoring using cohort identification

  • Author

    W H Inman N S Rawson

    William Inman, Nigel Rawson

  • Cite

    Br Med J (Clin Res Ed). 1987 Apr 4;294(6576):902

Non-steroidal anti-inflammatory drugs: Assessment of risks

  • Author

    W H Inman

    William Inman

  • Cite

    Eur J Rheumatol Inflamm. 1987;8(1):71-85

Enalapril-induced cough

  • Author

    W H Inman

    William Inman

  • Cite

    Lancet. 1986 Nov 22;2(8517):1218

Prescription event monitoring

  • Author

    W H Inman

    William Inman

  • Cite

    Lancet. 1986 Feb 22;1(8478):443

Adverse drug reactions

  • Author

    W H Inman

    William Inman

  • Cite

    Lancet. 1986 Feb 15;1(8477):383-4

Prescription-event monitoring. Recent experience with 5 NSAIDs

  • Author

    N S Rawson W H Inman

    Nigel Rawson, William Inman

  • Cite

    Med Toxicol. 1986;1 Suppl 1:79-82

Under-reporting of adverse drug reactions

  • Author

    W H Inman

    William Inman

  • Cite

    Br Med J (Clin Res Ed). 1985 May 4;290(6478):1355

Peptic ulcer and piroxicam

  • Author

    W H Inman N S Rawson

    William Inman, Nigel Rawson

  • Cite

    Br Med J (Clin Res Ed). 1985 Mar 23;290(6472):932-3

Side-effects of benoxaprofen

  • Author

    W H Inman N S Rawson

    William Inman, Nigel Rawson

  • Cite

    Lancet. 1984 Dec 8;2(8415):1336

Prescription-event monitoring and yellow cards

  • Author

    W H Inman

    William Inman

  • Cite

    Lancet. 1984 Jun 9;1(8389):1301

Postmarketing surveillance of adverse reactions to drugs

  • Author

    Inman WHW Snell ES

    William Inman, Snell ES

  • Cite

    BMJ. January 1984

Prescription-event monitoring. A preliminary study of benoxaprofen and fenbufen

  • Author

    W H Inman

    William Inman

  • Cite

    Acta Med Scand Suppl. 1984;683:119-26

Zomepirac and cardiovascular deaths

  • Author

    W H Inman N S Rawson

    William Inman, Nigel Rawson

  • Cite

    Lancet. 1983 Oct 15;2(8355):908

Yellow cards and green forms

  • Author

    W H Inman

    William Inman

  • Cite

    Practitioner. 1983 Sep;227(1383):1443-9

Erythromycin estolate and jaundice

  • Author

    W H Inman N S Rawson

    William Inman, Nigel Rawson

  • Cite

    Br Med J (Clin Res Ed). 1983 Jun 18;286(6382):1954-5

Adverse reactions to new drugs

  • Author

    W H Inman

    William Inman

  • Cite

    Br Med J (Clin Res Ed). 1983 Feb 26;286(6366):719-20

Prescription-event monitoring

  • Author

    W H Inman

    William Inman

  • Cite

    Br Med J (Clin Res Ed). 1982 Sep 18;285(6344):809-10

Postmarketing surveillance of adverse drug reactions in general practice. II: Prescription-event monitoring at the University of Southampton

  • Author

    W H Inman

    William Inman

  • Cite

    Br Med J (Clin Res Ed). 1981 Apr 11;282(6271):1216-7

Postmarketing surveillance of adverse drug reactions in general practice. I. Search for new methods

  • Author

    W H Inman

    William Inman

  • Cite

    Br Med J (Clin Res Ed). 1981 Apr 4;282(6270):1131-2

Oral contraceptives and fatal subarachnoid haemorrhage

  • Author

    W H Inman

    William Inman

  • Cite

    Br Med J. 1979 Dec 8;2(6203):1468-70

Risk of non-fatal cardiac failure and ischaemic heart disease with long acting beta 2 agonists

  • Author

    R M Martin N R Dunn S N Freemantle R D Mann

    Richard Martin, Nick Dunn, Shayne Freemantle, Ronald Mann

  • Cite

    Thorax. 1998 Jul;53(7):558-62